![[CytoReason in Calcalist] CytoReason raises $20 million from Pfizer for AI drug discovery and development platform](https://blog.ourcrowd.com/wp-content/uploads/2021/11/Calcalist-web.png)
Pfizer may also have choices to license the Israeli startup’s platform and illness fashions, and fund supplementary mission assist, in a deal probably value as much as $110 million over the following 5 years
Learn extra right here.
Pfizer may also have choices to license the Israeli startup’s platform and illness fashions, and fund supplementary mission assist, in a deal probably value as much as $110 million over the following 5 years
Learn extra right here.